Real‐world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program

OBJECTIVE: This study investigated early, real‐world outcomes with cenobamate (CNB) in a large series of patients with highly drug‐resistant epilepsy within a Spanish Expanded Access Program (EAP). METHOD: This was a multicenter, retrospective, observational study in 14 hospitals. Inclusion criteria...

Descripción completa

Detalles Bibliográficos
Autores principales: Villanueva, Vicente, Santos‐Carrasco, Daniel, Cabezudo‐García, Pablo, Gómez‐Ibáñez, Asier, Garcés, Mercedes, Serrano‐Castro, Pedro, Castro‐Vilanova, Maria D., Sayas, Débora, Lopez‐Gonzalez, Francisco J., Rodríguez‐Osorio, Xiana, Torres‐Gaona, Gustavo, Saiz‐Diaz, Rosa A., Hampel, Kevin G., Martinez‐Ferri, Meritxell, Aguilar‐Amat, Maria J., Mercedes‐Alvarez, Blanca, García‐Morales, Vanessa, del Villar‐Igea, Ana, Massot‐Tarrús, Andreu, Rodríguez‐Uranga, Juan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472366/
https://www.ncbi.nlm.nih.gov/pubmed/37149853
http://dx.doi.org/10.1002/epi4.12757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472366/
https://www.ncbi.nlm.nih.gov/pubmed/37149853
http://dx.doi.org/10.1002/epi4.12757

Ejemplares similares